HK1199727A1 - 抗細菌的哌啶基取代的 -二氫- 萘啶酮 - Google Patents

抗細菌的哌啶基取代的 -二氫- 萘啶酮

Info

Publication number
HK1199727A1
HK1199727A1 HK15100116.2A HK15100116A HK1199727A1 HK 1199727 A1 HK1199727 A1 HK 1199727A1 HK 15100116 A HK15100116 A HK 15100116A HK 1199727 A1 HK1199727 A1 HK 1199727A1
Authority
HK
Hong Kong
Prior art keywords
naphthyridinones
dihydro
antibacterial
piperidinyl substituted
piperidinyl
Prior art date
Application number
HK15100116.2A
Other languages
English (en)
Inventor
Jerme Emile Georges Guillemont
David Francis Alain Lanois
Magali Madeleine Simone Motte
Anil Koul
Wendy Mia Albert Balemans
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of HK1199727A1 publication Critical patent/HK1199727A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15100116.2A 2011-08-10 2015-01-07 抗細菌的哌啶基取代的 -二氫- 萘啶酮 HK1199727A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11177116 2011-08-10
PCT/EP2012/065730 WO2013021052A1 (en) 2011-08-10 2012-08-10 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones

Publications (1)

Publication Number Publication Date
HK1199727A1 true HK1199727A1 (zh) 2015-07-17

Family

ID=46724388

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15100116.2A HK1199727A1 (zh) 2011-08-10 2015-01-07 抗細菌的哌啶基取代的 -二氫- 萘啶酮
HK16111928.6A HK1223614A1 (zh) 2011-08-10 2016-10-17 抗細菌的哌啶基取代的 -二氫- 萘啶酮

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16111928.6A HK1223614A1 (zh) 2011-08-10 2016-10-17 抗細菌的哌啶基取代的 -二氫- 萘啶酮

Country Status (13)

Country Link
US (2) US9012634B2 (zh)
EP (1) EP2742047B1 (zh)
JP (2) JP6294822B2 (zh)
KR (1) KR101967174B1 (zh)
CN (2) CN105503869A (zh)
AU (1) AU2012293619B2 (zh)
BR (1) BR112014002958B1 (zh)
CA (1) CA2842531C (zh)
EA (1) EA201490435A1 (zh)
ES (1) ES2881681T3 (zh)
HK (2) HK1199727A1 (zh)
MX (1) MX363478B (zh)
WO (1) WO2013021052A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105503869A (zh) * 2011-08-10 2016-04-20 爱尔兰詹森科学公司 抗细菌的哌啶基取代的3,4-二氢-1h-[1,8]萘啶酮
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
WO2013080222A1 (en) * 2011-12-02 2013-06-06 Aurigene Discovery Technologies Limited Substituted pyridine derivatives as fabi inhibitors
US9062075B2 (en) 2011-12-02 2015-06-23 Aurigene Discovery Technologies Limited Tetrahydropyridine derivatives as FabI inhibitors
WO2014072930A2 (en) * 2012-11-09 2014-05-15 Aurigene Discovery Technologies Limited Fused pyridine derivatives as antibacterial agents
WO2014195844A1 (en) * 2013-06-04 2014-12-11 Aurigene Discovery Technologies Limited TETRAHYDROPYRIDINE DERIVATIVES AS FabI INHIBITORS
WO2015071780A1 (en) * 2013-11-12 2015-05-21 Aurigene Discovery Technologies Limited Alkylidine substituted heterocyclyl derivatives as anti-bacterial agents
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
CN107652226B (zh) * 2017-11-15 2020-03-31 上海皓伯化工科技有限公司 一种N-Boc-4-哌啶甲醛的制备方法
KR102037494B1 (ko) * 2017-12-11 2019-10-28 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
KR20190120112A (ko) 2019-10-08 2019-10-23 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
CN113527220A (zh) * 2021-07-26 2021-10-22 京博农化科技有限公司 一种脱硫丙硫菌唑异构体的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215123A (en) 1979-05-07 1980-07-29 American Home Products Corporation Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
JP4831907B2 (ja) 1999-10-08 2011-12-07 アフィニアム・ファーマシューティカルズ・インコーポレイテッド FabI阻害剤
CO5251401A1 (es) 1999-10-08 2003-02-28 Smithkline Beecham Corp Inhibidores de fab i
CZ302015B6 (cs) 1999-10-08 2010-09-08 Affinium Pharmaceuticals, Inc. Inhibitory Fab I
ATE420640T1 (de) 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
SI1828167T1 (sl) * 2004-06-04 2014-12-31 Debiopharm International Sa Forum "Apres-Demain" Akrilamidni derivati kot anitibiotična sredstva
US7732612B2 (en) 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
AU2010320963B2 (en) * 2009-11-18 2015-07-09 Fab Pharma Sas Novel heterocyclic acrylamides and their use as pharmaceuticals
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
CN105503869A (zh) * 2011-08-10 2016-04-20 爱尔兰詹森科学公司 抗细菌的哌啶基取代的3,4-二氢-1h-[1,8]萘啶酮
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم

Also Published As

Publication number Publication date
BR112014002958A2 (pt) 2017-02-21
CN103917540B (zh) 2016-03-16
JP2014521715A (ja) 2014-08-28
ES2881681T3 (es) 2021-11-30
AU2012293619B2 (en) 2017-05-04
US9012634B2 (en) 2015-04-21
US20150158866A1 (en) 2015-06-11
JP2017222647A (ja) 2017-12-21
CA2842531A1 (en) 2013-02-14
CA2842531C (en) 2019-07-16
JP6552550B2 (ja) 2019-07-31
US9598407B2 (en) 2017-03-21
EP2742047B1 (en) 2021-05-12
MX2014001599A (es) 2014-04-25
AU2012293619A1 (en) 2014-02-06
HK1223614A1 (zh) 2017-08-04
WO2013021052A1 (en) 2013-02-14
KR101967174B1 (ko) 2019-04-09
BR112014002958B1 (pt) 2020-10-06
CN105503869A (zh) 2016-04-20
JP6294822B2 (ja) 2018-03-14
MX363478B (es) 2019-03-22
US20140163038A1 (en) 2014-06-12
CN103917540A (zh) 2014-07-09
EP2742047A1 (en) 2014-06-18
EA201490435A1 (ru) 2014-06-30
KR20140079759A (ko) 2014-06-27

Similar Documents

Publication Publication Date Title
HK1223614A1 (zh) 抗細菌的哌啶基取代的 -二氫- 萘啶酮
EP2875029B8 (en) 5,5-heteroaromatic anti-infective compounds
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
AP2013007254A0 (en) 4-Aryl-N-phenyl-1,3,5,-triazin-2-amines containinga sulfoximine group
EP2935214A4 (en) 1,4-PYRIDONES COMPOUNDS
GB201112931D0 (en) Metail 3
PL2531492T3 (pl) Pochodne 1,2,4-triazyno-4-aminy
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
HK1197242A1 (zh) 氟甲基- -二氫- 噁嗪類
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
IL232463A0 (en) Antibiotic history of 2-oxo-oxazolidine-3,5-diyl
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
HK1254403A1 (zh) 抗菌的高哌啶基取代的3,4二氫-1h[1,8]萘啶酮類
EP2763539A4 (en) ANTIBACTERIAL COMPOUNDS
HK1207317A1 (zh) 取代的 -萘啶
MY165626A (en) 1,2,4,-triazolone derivative
EP2851075A4 (en) PREPARATION WITH 6,7-UNSATED 7-CARBAMOYLMORPHINANE DERIVATIVE
AU5074P (en) Crackerjack 2 xTriticosecale
EP2865747A4 (en) 4,6-HEXADECADIENE-2,4-DICARBOXYLIC ACID DERIVATIVE
GB201119958D0 (en) Antibacterial derivatives
GB201119961D0 (en) Antibacterial derivatives
AU2011903305A0 (en) Construction Bar
GB201119739D0 (en) Corcost 5863
GB201114541D0 (en) Pakaging 27

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230815